Original Contributions |
From the Department of Medical Biochemistry, University of Graz, Graz, Austria.
Correspondence to Dr Wolfgang F. Graier, Department of Medical Biochemistry, University of Graz, Harrachgasse 21/III, A-8010 Graz, Austria. E-mail wolfgang.graier{at}kfunigraz.ac.at
| Abstract |
|---|
|
|
|---|
Key Words: cytochrome P450 epoxygenase inositol-1,4,5-trisphosphate membrane fluidity membrane potential tyrosine kinase
| Introduction |
|---|
|
|
|---|
Few studies have examined the effect of superoxide anions on
endothelial signal transduction mechanisms. Franceschi
et al10 showed that superoxide anions produced by
the xanthine oxidase/hypoxanthine (XO/HX) reaction resulted in
short-term membrane hyperpolarization in
endothelial cells due to stimulation of
Ca2+ entry through a nonvoltage-dependent
mechanism.10 11 In agreement with the findings of
increased [Ca2+]i,
enhanced intracellular prostaglandin
I2 formation after incubation with XO/HX was
described in human umbilical vein endothelial
cells.12 In most of these studies, very high
concentrations of superoxide anions were used. For example, in
coronary artery smooth muscle cells, attenuation of
angiotensin IIinitiated contraction by such high
superoxide anion concentrations (>1 mU/mL XO) did not differ from that
induced by H2O2 (>30
µmol/L).13 We have shown that increased
formation of superoxide anion during exposure to a high
D-glucose concentration elicits changes in
endothelial Ca2+
signaling.14 However, the superoxide anion levels
mediated by high D-glucose
treatment,14 for example, were much lower than
those used in the other studies mentioned above while exposure time was
prolonged for several hours. Under such conditions, superoxide anion
had no short-term effects on resting endothelial
[Ca2+]i, whereas the
mobilization of Ca2+ evoked by bradykinin was
enhanced.14 So far, no detailed studies have been
performed to understand how physiological
concentrations of superoxide anions affect endothelial
Ca2+ signaling. As shown in Figure 1
, endothelial cell
stimulation with an agonist, such as bradykinin or ATP, results in G
proteinmediated activation of phospholipase C and the formation of
inositol-1,4,5-trisphosphate (IP3), which in turn
releases Ca2+ from intracellular
Ca2+ pools. In addition to the intracellular
Ca2+ release, an extracellular
Ca2+ influx is activated due to the
depletion of intracellular Ca2+
pools,15 thus representing a
so-called "capacitative Ca2+ entry"
pathway.16 17
|
In the current study, the mechanism whereby prolonged exposure to small
superoxide anion concentrations affects endothelial
Ca2+ signaling was investigated further. The
effect of pretreatment with superoxide anions on
endothelial Ca2+ signaling (ie,
intracellular Ca2+
mobilization18 and capacitative
Ca2+ entry19 ) and
mechanisms previously shown to be involved in
endothelial Ca2+ signaling
(Figure 1
), such as formation of
IP3,18 cytochrome P450
epoxygenase,19 20 membrane
hyperpolarization,21 tyrosine
kinase (TK),22 and membrane fluidity, were
assessed.
| Methods |
|---|
|
|
|---|
Cell Culture
Endothelial cells were isolated from porcine
aortae by enzymatic digestion with 200 U/mL collagenase
(type II) in Dulbecco's minimal essential medium (DMEM) plus dilutions
of (vol/vol) 0.02 amino acids and 0.01 vitamins plus trypsin
inhibitor (soybean type I, 1 mg/mL) as described
previously.19 Cells were cultured in Opti-DMEM
containing 3% FCS. Only cells from passage 1 or 2 were used for
experiments (
10 to 14 days in culture).
Ca2+ Measurement
Free [Ca2+]i was
determined in porcine aortic endothelial cells in
suspension or monolayer as indicated by the fura 2 technique as
previously described.19 In brief, cells were
incubated with DMEM containing 2 µmol/L fura 2-AM in the dark
for 45 minutes (suspended cell experiments) or 30 minutes (single-cell
experiments) at 37°C. Afterward, the cells were centrifuged
and resuspended in DMEM. Just before the experiment, cells were
centrifuged and resuspended in nominal
Ca2+-free (ie,
10 µmol/L free
extracellular Ca2+) HEPES-buffered solution
containing (in mmol/L) 145 NaCl, 5 KCl, 1
MgCl2, and 10 HEPES, pH 7.4.
[Ca2+]i was monitored
every 0.25 to 2.0 seconds (depending on the instrument used) as the
ratio of 340 and 380 nm excitation at 510 nm emission.
To study specifically the effects of superoxide anions on the stimulation of capacitative Ca2+ entry, Mn2+ quench experiments were performed as previously described.19 23 24 In brief, this approach is based on use of the surrogate divalent cation Mn2+, which enters the cells through the channels involved in capacitative Ca2+ entry. However, the entry of Mn2+ into fura 2loaded cells induces a decrease in fluorescence at 360 nm excitation and 510 nm emission (ie, the isosbestic, Ca2+-insensitive wavelength of fura 2). The amount of Mn2+ entering the cells is proportional to the fractional decrease in fluorescence relative to the initial intensity.
Data Acquisition
In view of the reported problems concerning
[Ca2+]i calibration in
our system19 and the general uncertainties of the
calibration techniques,25
[Ca2+]i in each
experiment was expressed as the 340- to 380-nm emission ratio. Because
of minor differences between the instruments used (Hitachi F2000,
Hitachi F4500, and Perkin-Elmer LS-50B/FFA), caution is necessary when
comparing given ratio units between different figures. Thus, for each
experimental series, results were compared with those obtained in
control cells (ie, preincubated in the absence of XO) performed daily
and shown in each figure.
Superoxide Anion Treatment
Superoxide anions were generated by the reaction of XO with HX
in DMEM (containing 1.8 mmol/L Ca2+) for
incubation with the cells; however, phenol redfree DMEM was used for
superoxide anion measurements. The generation of superoxide anions was
determined as the difference in the reduction of ferricytochrome
c (10 µmol/L, horse heart type III) in the absence or
presence of SOD (476 U/mL). The reduction of ferricytochrome
c was monitored at 550 nm. The difference in absorption
between samples in the absence and presence of SOD directly shows
extinction due to superoxide anionrelated reduction of
ferricytochrome c. Concentrations of superoxide anions were
calculated by using the molar extinction coefficient of the reduced
form of ferricytochrome c
(
=21 000).14 Production of superoxide
anions was controlled for each cell pretreatment procedure in phenol
redfree DMEM without added cells.
Cells were incubated in DMEM containing 1 mmol/L HX with or without XO at the concentrations indicated for 1 to 3 hours. Experiments were performed in the absence of XO/HX after a 45-minute equilibration (for IP3 measurements, 15 minutes) of the cells in normal DMEM. The percentage of XO-treated cells responding to agonist stimulation was comparable to that of cells treated with HX alone. Likewise, XO up to 1000 µU/mL did not affect cell viability or size, as determined by trypan blue incorporation (viability only) and the Schärfe cell counter (viability and cell size, Casy-1).
IP3 Formation
IP3 was determined by using a customized
radioactive binding assay (Biotrak, Amersham International) as
described previously.26 In brief,
endothelial cells were cultured to confluence in 6-well
plates. Before experimentation, the cells were washed twice with
HEPES-buffered solution (plus 2.5 mmol/L
CaCl2) and equilibrated at 37°C in 1 mL of the
salt solution. After 15 minutes, the compound to be tested was added at
a dilution of 1:100. After a 30-second incubation, the experiment was
stopped by the addition of 200 µL of 20% chilled
HClO4. After 20 minutes on ice, the pH of the
supernatant was adjusted to 7.5 by adding KOH. After 15 minutes at
4°C, the samples were centrifuged for 15 minutes at
2000g, and the resulting supernatant was used for
determination of IP3 content with the radioactive
binding assay.
Microsomal Cytochrome P450 Monooxygenase (CYP450
MO)
Microsomal CYP450 MO was measured as previously
described.20 In brief, cells were suspended in
intracellular-like buffer containing (in mmol/L) 150 KCl, 10
MgCl2 , and 50 Tris, with pH adjusted to 7.5.
1-Ethoxypyrene-3,6,8-tris-(dimethylsulfonamide) (25 µmol/L) was
added under constant stirring, and cells were
permeabilized with 1 mg/mL saponin in the presence of
an NADPH-regenerating system (25 IU isocitric dehydrogenase
[NADP+], 8 mmol/L DL-isocitric
acid, and 1 mmol/L NADP+). As shown
recently, enzyme activity was further enhanced by depletion of
intracellular Ca2+ stores with thapsigargin (TG;
2 µmol/L). Activity of microsomal CYP450 MO was recorded at
495 nm excitation and 550 nm emission and was calculated by using a
standard calibration curve.20
Membrane Potential
Variations in membrane potential were measured by using
DiBAC4(5) as previously
described.20 In brief, cultured
endothelial cells were suspended in a buffer
(
9.3x106 cells/mL) containing (in
mmol/L) choline chloride 145, KCl 5, HEPES-free acid 10, and
MgCl2 1, adjusted with KOH to pH 7.4. Under
constant stirring, DiBAC4(5) (1 µmol/L) was
added. After an equilibration period, the compound to be tested was
added. Membrane potential was monitored at 590 nm excitation and 616 nm
emission. Calibration of the DiBAC4(5) signal was
performed by cumulatively adding KCl (final concentration, 5 to 70
mmol/L) to the solution in the presence of gramicidin D (800 nmol/L) as
described recently.20 The membrane potential for
each KCl concentration was calculated according Vieira et
al27 and was correlated with the
fluorescence readings. Resting potential against 5 mmol/L
KCl was expected to be -34 mV,28 owing to the
known problems for estimation of absolute membrane potentials with the
potentially sensitive fluorescent
probes.29 All data were expressed as changes in
millivolts from resting potentials.
TK Activity
Endothelial TK activity was measured by using a
customized photometric protein TK assay kit from Calbiochem-Novabiochem
International as previously described.20 In
brief, cell lysates were obtained by sonication of the cell suspension
on ice in a buffer containing (in mmol/L) Tris 20, NaCl 50, EDTA
1, EGTA 1, PMSF 0.2, Na3VO4
0.2 , and mercaptoethanol 5; 1 µg/mL pepstatin; and 0.5 µg/mL
leupeptin, with the pH adjusted to 7.4. Mg2+ and
ATP were added to cell extract aliquots, and the mixture was incubated
in the absence or presence of XO/HX as indicated.
Phosphorylation of an immobilized substrate
was determined by a horseradish peroxidaselabeled
phosphotyrosine-specific antibody, and the conversion of
tetramethylbenzidine as a substrate of horseradish peroxidase was
monitored in a plate-reader photometer at 450 nm.
Membrane Viscosity
Membrane viscosity was measured by using a technique based on
the depolarization of fluorescence light emitted from
TMA-DPH.30 In brief, cultured
endothelial cells were washed twice and harvested by
enzymatic digestion (trypsin), centrifuged, resuspended in
HEPES buffer (see above), and placed in a thermostatically controlled
cuvette in a Hitachi F-2000 spectrofluorometer equipped with polarizers
at the excitation site and an analyzer at the emission site.
Before the addition of the dye (TMA-DPH, 20 µmol/L),
autofluorescence was monitored at each setting of the polarizer
and analyzer. After addition of TMA-DPH, cells were
equilibrated at 37°C in the dark. Fluorescence intensity was
monitored at 355 nm excitation and 450 nm emission at settings
Ivv (both polarizer and analyzer in
the vertical position) and Ivh (polarizer
in the vertical position and analyzer in the horizontal
position). After subtraction of autofluorescence at each
setting, membrane viscosity was calculated according to the following
equation30 :
h=[(Ivv/Ivh)-1]/[0.73-0.27(Ivv/Ivh)],
where h is the viscosity expressed in poises.
Additional studies were performed in cell monolayers.
Endothelial cells were grown on glass coverslips (1-cm
diameter) for
16 hours. For the experiments, the coverslip was
mounted in the cuvette at an angle of 60°. The experimental procedure
was identical to that mentioned above.
Intracellular pH
Intracellular pH was measured as previously
described.26 In brief,
endothelial cells were loaded in DMEM for 45 minutes
with 10 µmol/L SNARF-1/AM in the dark. An in situ calibration
after each experiment was performed in the presence of 10 µmol/L
nigericin for the calculation of pH.
Statistics
All data represent the mean±SEM. Experiments were
performed in triplicate with at least 3 different cell preparations.
Data evaluation was performed by ANOVA. Differences, estimated by
Scheffé's F test, were considered statistically significant
at P<0.05.
| Results |
|---|
|
|
|---|
|
Ca2+ Signaling: Receptor-Dependent Agonists
The effects of XO/HX pretreatment on the mobilization of
Ca2+ induced by the endothelial
agonists bradykinin (Figure 3A
) and ATP
(Figure 3B
) were examined. For this series of experiments, the cells
were first incubated with or without 150 µU/mL XO for 1 hour in DMEM
containing 1 mmol/L HX. The effects of the agonists were initiated
in nominally Ca2+-free solution to assess the
release of Ca2+ from intracellular stores.
Afterward, in the continuous presence of the agonist (bradykinin or
ATP), 2.5 mmol/L Ca2+ was added to the bath
to monitor the elevation in cytosolic Ca2+ due to
an influx from the extracellular medium. As shown in Figure 3A
and 3B
,
both the release of intracellular Ca2+ and the
influx stimulated by bradykinin and ATP were significantly enhanced in
cells treated with XO/HX. By contrast, the magnitude of
Ca2+ entry obtained after addition of 2.5
mmol/L Ca2+ in the absence of an agonist was not
changed significantly by the XO/HX treatment (Figure 3B
). Coincubation
with SOD (250 U/mL) during exposure to the anion-generating system
normalized endothelial Ca2+
signaling to ATP (Figure 3B
), whereas SOD did not affect
endothelial Ca2+ signaling in
control cells (no XO present during preincubation procedure; data
not shown). In contrast to SOD, coincubation with cycloheximide during
the XO/HX preincubation period had no effect on the enhancement of
endothelial Ca2+ signaling by
superoxide anion (data not shown). There was no detectable effect on
either ATP-induced Ca2+ release or capacitative
Ca2+ entry when the cells were preincubated with
150 µU/mL XO in the absence of HX (data not shown).
|
When endothelial cells were stimulated with bradykinin (100 nmol/L) in the presence of 2.5 mmol/L extracellular Ca2+, both the initial spike and the plateau phase, which remained constant for at least 10 minutes, were enhanced in cells pretreated for 1 hour with XO/HX (150 µU/mL and 1 mmol/L, respectively) by 63% and 84%, respectively (data not shown). In agreement with our findings that pretreatment with XO/HX did not affect basal endothelial Ca2+ levels, preincubation with XO/HX (150 µU/mL and 1 mmol/L) for 1 hour did not affect basal intracellular pH (control, 7.53±0.13; with XO/HX, 7.41±0.09; n=7; NS versus control).
Figure 4A
and 4B
illustrates the time
dependence of the enhancement of Ca2+ signaling
induced by preincubating the cells with XO/HX. After 30 minutes, a
slight increase in Ca2+ signaling was detectable,
and a 1-hour preincubation showed the maximal effect, which was not
enhanced further by incubation durations up to 3 hours (data not
shown). Conversely, endothelial
Ca2+ signaling was restored 12 hours after
removal of XO/HX after a 1-hour treatment.
|
The concentration dependence of XO in the presence of 1 mmol/L HX
was assessed on bradykinin-induced Ca2+
signaling, according to the protocols shown in Figure 4A
and 4B
(Figure 4C
). Threshold potentiation could be observed with a concentration of
XO as low as 100 µU/mL. To demonstrate the effect of superoxide
anions on bradykinin-stimulated capacitative Ca2+
entry more precisely, Mn2+ quench studies were
performed (Figure 4D
). In agreement with the results on capacitative
Ca2+ entry, Mn2+ quench in
response to stimulation with 100 nmol/L bradykinin was significantly
enhanced in cells preincubated with 150 µU/mL XO in the presence of
1 mmol/L HX for 1 hour (Figure 4D
). Coincubation with SOD
completely prevented the effect of the XO/HX treatment on the
bradykinin-induced Mn2+ quench (data not
shown).
In contrast to SOD, coincubation with the TK
inhibitor tyrphostin A48 (714 nmol/L) failed to affect
XO/HX-mediated alterations in endothelial
Ca2+ signaling in response to 100 nmol/L
bradykinin (Figure 5
). In agreement with
these findings, coincubation with 5 µmol/L erbstatin during
preincubation with 150 µU/mL XO in the presence of 1 mmol/L HX
also failed to increase endothelial
Ca2+ signaling in response to 100 nmol/L
bradykinin (data not shown).
|
Because agonist-induced Ca2+ release was shown to
be due to the formation of
IP3,18 the effect of
preincubation with the superoxide aniongenerating system on
endothelial IP3 formation was
studied (Figure 6
). A 1-hour
preincubation with 150 µU/mL XO in the presence of HX had no effect
on basal IP3 levels, whereas
IP3 formation due to a 30-second stimulation with
100 nmol/L bradykinin was increased significantly (Figure 6
).
|
IP3-Independent Capacitative Ca2+
Entry
Endothelial capacitative
Ca2+ entry depends on the depletion of
IP3-sensitive Ca2+
stores.15 To investigate whether the effect of
superoxide anions on endothelial
Ca2+ entry was due only to increased
Ca2+ store depletion by
IP3, the effect of XO/HX treatment on
endothelial Ca2+ signaling
induced by the IP3-independent
Ca2+ mobilizers
2,5-di-(tert-butyl)-1,4-benzohydroquinone (BHQ; Figure 7A
)19 and
thapsigargin (TG; Figure 7B
)19 was studied.
Whereas pretreatment with XO/HX had no effect on intracellular
Ca2+ release induced by either BHQ (Figure 7A
) or
TG (Figure 7B
), Ca2+ entry after stimulation with
either BHQ (Figure 7A
) or TG (Figure 7B
) was significantly enhanced in
cells pretreated with XO/HX.
|
Microsomal CYP450 MO Activity
The importance of microsomal CYP450 MO activity for
endothelial Ca2+ entry and
membrane potential has been demonstrated in endothelial
cells.19 20 Thus, the effect of treatment with
superoxide anions on CYP450 MO activity in endothelial
cells was tested (Figure 8A
).
Endothelial cells were preincubated for 1 hour with 150
µU/mL XO in the presence of 1 mmol/L HX, and CYP450 MO was
activated by depletion of IP3-sensitive
stores with 2 µmol/L TG.31 In cells
preincubated with XO/HX, CYP450 MO activity was augmented by 64%
(Figure 8A
). Coincubation with SOD (450 U/mL) prevented the effect of
XO/HX on endothelial CYP450 MO (data not shown).
Inhibition of endothelial NO synthase with
NG-nitro-L-arginine (300
µmol/L) had no effect on the influence of XO/HX on
endothelial CYP450 MO activity (Figure 8A
).
|
Membrane Hyperpolarization
In addition to CYP450 MO, membrane
hyperpolarization is known to play a crucial role
in endothelial capacitative Ca2+
entry.20 21 Thus, the effect of preincubation
with the superoxide aniongenerating system XO/HX on TG-induced
membrane hyperpolarization was studied (Figure 8B
).
Although TG-induced intracellular Ca2+ release
was not altered by XO/HX (see above), the latter augmented membrane
hyperpolarization by 2 µmol/L TG in nominal
Ca2+-free solution by 48% (Figure 8B
). Membrane
hyperpolarization to TG in untreated as well as
XO/HX-pretreated endothelial cells was abolished in the
presence of 10 mmol/L tetrabutylammonium chloride (data not
shown).
TK
Preincubation with XO in the presence of 1 mmol/L HX yielded
increased Ca2+-activated TK activity in
cultured endothelial cells. Use of 150 and 300 µU/mL
XO during the preincubation period of 45 minutes increased
endothelial TK activity by 97% and 156%, respectively
(Figure 9A
). The TK
inhibitors erbstatin (100 µmol/L) and tyrphostin A48
(714 nmol/L) strongly inhibited all TK activity in lysates of untreated
and HX/XO-pretreated cells (control, 4.59±1.06 and 3.33±1.31 U/mg
protein; XO/HX, 3.66±0.76 and 4.73±1.27 U/mg protein; n=3).
|
Membrane Viscosity
Exposure of endothelial cells to 150 µU/mL XO in
the presence of 1 mmol/L HX significantly reduced membrane
viscosity (Figure 9B
). This effect was completely prevented when 300
U/mL SOD was present during XO/HX treatment (Figure 9B
) or when no
HX was present (data not shown).
To investigate whether increased membrane stiffness might result in an
effect opposite to increased membrane fluidity,
endothelial cells were loaded with
cholesterol. As shown in Figure 10A
, incubating the cells for 30 or 60
minutes with 250 µmol/L cholesterol (from 25
mmol/L stock in ethanol) yielded increases in membrane viscosity of
113% and 135%, respectively. Moreover, cholesterol
loading for 30 or 60 minutes attenuated bradykinin-induced
intracellular Ca2+ release and capacitative
Ca2+ entry by 26% and 47% or 63% and 68%,
respectively (Figure 10B
).
|
The correlation between membrane viscosity and agonist-induced
intracellular Ca2+ release (100 nmol/L
bradykinin) was negative (Figure 11A
).
Endothelial cells were incubated for 20 or 60 minutes
in DMEM containing 150 µU/mL XO and 1 mmol/L HX to decrease cell
membrane viscosity. To increase cell membrane viscosity, cells were
exposed to 25 or 250 µmol/L cholesterol for 30 or 60
minutes. Similar results were obtained when endothelial
capacitative Ca2+ entry activity was correlated
with membrane viscosity (data not shown). In agreement with these
findings on bradykinin-induced Ca2+ signaling,
alterations of TG-induced hyperpolarization were
negatively correlated with changes in membrane viscosity (Figure 11B
).
|
| Discussion |
|---|
|
|
|---|
Tan et al34 showed that oxygen-derived free radicals stimulate adenylyl cyclase via TK activation in A10 cells. In endothelial cells, the TK inhibitor tyrphostin A48 had no effect on superoxide anionmediated augmentation of agonist-initiated Ca2+ signaling. These findings do not support the involvement of tyrphostin A48-sensitive TKs in XO/HX-evoked changes in Ca2+ signaling. However, because it is possible that 1 single TK inhibitor is not able to prevent all TK activity, the involvement of TK in XO/HX-mediated changes in Ca2+ signaling cannot be excluded. In spite of this, superoxide anions actually enhanced endothelial TK activity. Fleming and coworkers22 have suggested that TK activity is involved in endothelial capacitative Ca2+ entry. On the contrary, Vostal and Shafer35 found that capacitative Ca2+ entry was independent of any TK activity. Although our results show that an increase in tyrphostin A48-sensitive TK activity may not be involved in the enhancement of capacitative Ca2+ entry after XO/HX treatment, these findings do not give any indication whether TKs are involved in endothelial Ca2+ signaling. Moreover, it needs to be investigated whether the observed increase in TK activity by XO/HX might influence other TK-mediated cellular functions, like shear stressactivated NO formation.36
The concentration-response relationship of superoxide anions with respect to amplification of intracellular Ca2+ release was identical to that for capacitative Ca2+/Mn2+ entry. The augmented intracellular Ca2+ release in response to the IP3-generating compounds bradykinin and ATP after superoxide anion treatment might be due to enhanced IP3 formation on addition of bradykinin to XO/HX-treated cells. Similar findings were described in airway epithelium.37 These data indicate that the superoxide anion might affect either phospholipase C activity or receptorG proteinphospholipase C coupling. Radical-mediated changes in G protein activity/coupling have been reported for NO on Go proteins in neurons38 and for oxyradicals for isoproterenol receptorcoupled Gi and GS proteins in ischemic/reperfused hearts.39 Additional studies are needed to clarify whether the reported changes in IP3 production by superoxide anion preincubation are due to changes in G protein activity/coupling or phospholipase C activity.
Because intracellular Ca2+ store depletion
regulates the activity of capacitative Ca2+ entry
pathways in endothelial cells,15
one might speculate that the effect of superoxide anions on
capacitative Ca2+/Mn2+
entry is due to the pronounced depletion of Ca2+
pools. Our finding that BHQ- and TG-induced capacitative
Ca2+ entry was also enhanced in XO/HX-treated
cells while intracellular Ca2+ release remained
unchanged after superoxide anion treatment indicates that in addition
to its effect on IP3 formation, XO/HX directly
affects the mechanism(s) involved in capacitative
Ca2+/Mn2+ entry. The
mechanisms of capacitative Ca2+ entry regulation
in endothelial cells are still poorly understood
(Figure 1
).40 41 We have provided evidence for
the involvement of CYP450 MOderived arachidonic acid
metabolites, the epoxyeicosatrienoic acids (EETs), in
autacoid-stimulated capacitative Ca2+ entry and
membrane
hyperpolarization.19 20
Although membrane hyperpolarization does not open
the capacitative Ca2+ entry pathway in
endothelial cells, it provides the driving force for
Ca2+ to enter the
cell.21 42 Because CYP450 MO activity was
enhanced by preincubation with XO/HX, one might expect that the
enhanced formation of EETs results in augmentation of
endothelial capacitative
Ca2+/Mn2+ entry due to
enhanced EET-mediated membrane hyperpolarization.
Such enhancement of capacitative
Ca2+/Mn2+ entry by enhanced
membrane hyperpolarization in
endothelial cells was described for the
KATP channel opener
Hoe-23443 and for KCa
channel activation by cAMP.44 In addition, direct
effects of EETs on the capacitative Ca2+ entry
pathway itself are also possible.
In agreement with our findings, in atherosclerotic vessels agonist-induced (ie, Ca2+-mediated) production of NO is augmented,45 although reduced NO-mediated relaxation is observed owing to degradation of NO by oxygen free radicals.46 It needs to be investigated whether superoxide anions may serve as mediators of a compensatory adaptation of the endothelium in states with increased oxygen radical production (eg, hypercholesterolemia or hyperglycemia) to maintain the Ca2+-mediated release of vasodilator mediators, although the bioactivity of NO is diminished owing to its degradation by free radicals.
Because cycloheximide had no effect on superoxide anioninitiated
changes in endothelial Ca2+
signaling, the involvement of nuclear responses via superoxide
anioninitiated transcription factors (eg, nuclear factor-
B)
followed by changes in gene expression resulting in an altered
Ca2+ signaling cascade might be excluded in the
short-term model used in this study.
It is possible that each mechanism described might have specific superoxide anionsensitive elements or that superoxide anions affect 1 parameter common to all mechanisms studied. Such a parameter common to all phenomena studied could be membrane fluidity. In agreement with reports from the literature,47 incubation with XO/HX decreased membrane viscosity in endothelial cells. This mechanism was prevented by SOD. In contrast, cholesterol loading of endothelial cell membranes yielded an increase in membrane viscosity,48 which was associated with a decrease in bradykinin-initiated Ca2+ signaling (ie, intracellular Ca2+ release and capacitative Ca2+ entry) and TG-induced membrane hyperpolarization. In the current work, a negative correlation between membrane viscosity and agonist-stimulated intracellular Ca2+ release and TG-induced hyperpolarization could be demonstrated, suggesting that the superoxide anionmediated decrease in membrane viscosity might have significant impact on endothelial Ca2+ signaling mechanisms. In agreement with our findings, increased phospholipase C activity in response to agonist by decreased membrane viscosity was shown in the mouse brain, heart, and liver49 and in rat ventricular myocytes.50 Similar to changes in plasmalemmal enzyme/channel activity by modulations in cell membrane viscosity, microsomal enzyme activities are altered by changes in fluidity of the microsomal membrane.51 Such increased microsomal membrane fluidity might explain the enhanced microsomal CYP450 MO activity after exposure of endothelial cells to XO/HX presented here. Other than membrane-bound enzymes, changes in membrane viscosity have also been demonstrated to modulate Na+, K+, and Ca2+ channel activity.52 53 Additional studies are necessary to clarify whether the observed increase in membrane hyperpolarization in XO/HX-pretreated cells is due to direct modulation of membrane channel activity (eg, KCa channels) or an increase in activity of microsomal CYP450 MOs.
In this study, an additional role for superoxide anions beside their
involvement in the development of cellular/vascular dysfunction is
proposed. We have demonstrated that superoxide anions modulate the
mechanisms involved in endothelial
Ca2+ signaling shown in Figure 1
(phospholipase
C, membrane hyperpolarization, TK, and CYP450 MO).
These effects of superoxide anions might result in enhanced NO
biosynthesis during enhanced superoxide
formation,14 45 whereas on the other hand,
superoxide anions attenuate NO bioactivity.45 54
Additional studies are necessary to understand under which
circumstances the deleterious properties of superoxide anions overcome
the beneficial effects reported here.
| Acknowledgments |
|---|
Received October 16, 1997; accepted March 27, 1998.
| References |
|---|
|
|
|---|
2. Mügge A, Brandes RP, Böger RH, Dweger A, Bode-Böger S, Kienke S, Frölich JC, Lichtlen PR. Vascular release of superoxide radicals is enhanced in hypercholesterolemic rabbits. J Cardiovasc Pharmacol. 1994;24:994998.[Medline] [Order article via Infotrieve]
3. Michiels C, Arnould T, Houbion A, Remacle J. Human umbilical vein endothelial cells submitted to hypoxia-reoxygenation in vitro: implication of free radicals, xanthine oxidase, and energy deficiency. J Cell Physiol. 1992;153:5361.[Medline] [Order article via Infotrieve]
4. McCuskey RS, Urbaschek R, Urbaschek B. The microcirculation during endotoxemia. Cardiovasc Res. 1996;32:752763.[Medline] [Order article via Infotrieve]
5.
Tesfamariam B, Cohen RA. Free radicals mediate
endothelial cell dysfunction caused by elevated
glucose. Am J Physiol. 1992;263:H321H326.
6. Mazière C, Auclair M, Rose-Robert F, Leflon P, Mazière JC. Glucose-enriched medium enhances cell-mediated low density lipoprotein peroxidation. FEBS Lett. 1995;363:277279.[Medline] [Order article via Infotrieve]
7. Curcio F, Ceriello A. Decreased cultured endothelial cell proliferation in high glucose medium is reversed by antioxidants: new insights on the pathophysiological mechanisms of diabetic vascular complications. In Vitro Cell Dev Biol. 1992;28A:787790.
8. Cominacini L, Garbin U, Pasini AF, Davoli A, Campagnola M, Contessi GB, Pastorino AM, Lo-Cascio V. Antioxidants inhibit the expression of intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells. Free Radic Biol Med. 1997;22:117127.[Medline] [Order article via Infotrieve]
9. Gumusel B, Tel BC, Demirdamar R, Sahin-Erdemli I. Reactive oxygen species-induced impairment of endothelium-dependent relaxation in rat aortic rings: protection by L-arginine. Eur J Pharmacol. 1996;306:107112.[Medline] [Order article via Infotrieve]
10. Franceschi D, Graham D, Sarasua M, Zollinger RM. Mechanisms of oxygen free radical-induced calcium overload in endothelial cells. Surgery. 1990;108:292297.[Medline] [Order article via Infotrieve]
11. Dreher D, Junod AF. Differential effects of superoxide, hydrogen peroxide, and hydroxyl radical on intracellular calcium in human endothelial cells. J Cell Physiol. 1995;162:147153.[Medline] [Order article via Infotrieve]
12.
Shatos MA, Doherty JM, Hoak JC. Alterations in human
vascular endothelial cell function by oxygen free
radicals. Arterioscler Thromb. 1991;11:594601.
13.
Grover AK, Samson SE, Fomin VP, Werstiuk ES. Effects of
peroxide and superoxide on coronary artery: ANG II response and
sarcoplasmic reticulum Ca2+
pump. Am J Physiol. 1995;269:C546C553.
14. Graier WF, Simecek S, Kukovetz WR, Kostner GM. High-D-glucose-induced changes in endothelial Ca2+/EDRF signaling is due to generation of superoxide anions. Diabetes. 1996;45:13861395.[Abstract]
15. Schilling WP, Cabello OA, Rajan L. Depletion of the inositol 1,4,5-trisphosphate-sensitive intracellular Ca2+ store in vascular endothelial cells activates the agonist-sensitive Ca2+-influx pathway. Biochem J. 1992;284:521530.
16. Putney JW. Capacitative calcium entry revisited. Cell Calcium. 1990;11:611624.[Medline] [Order article via Infotrieve]
17. Putney JW. The capacitative model for receptor-activated calcium entry. Adv Pharmacol. 1991;22:251269.
18. Freay A, Johns A, Adams DJ, Ryan US, VanBreemen C. Bradykinin and inositol 1,4,5-trisphosphate-stimulated calcium release from intracellular stores in cultured bovine endothelial cells. Pflügers Arch. 1989;414:377384.[Medline] [Order article via Infotrieve]
19.
Graier WF, Simecek S, Sturek M. Cytochrome P450
mono-oxygenase-regulated signaling of
endothelial Ca2+
entry. J Physiol London. 1995;482:259274.
20. Hoebel BG, Kostner GM, Graier WF. Activation of microsomal cytochrome P450 mono-oxygenase by Ca2+ store depletion and its contribution to Ca2+ entry in porcine aortic endothelial cells. Br J Pharmacol. 1997;121:15791588.[Medline] [Order article via Infotrieve]
21.
Busse R, Fichter H, Lückhoff A, Kohlhardt M.
Hyperpolarization and increased free calcium in
acetylcholine-stimulated endothelial cells.
Am J Physiol. 1988;255:H965H969.
22.
Fleming I, Fisslthaler B, Busse R. Calcium signaling in
endothelial cells involves activation of tyrosine
kinase and leads to activation of mitogen-activated protein
kinase. Circ Res. 1995;76:522529.
23. Alvarez J, Montero M, García-Sancho J. Cytochrome P-450 may link intracellular Ca2+ stores with plasma membrane Ca2+ influx. Biochem. J. 1991;274:193197.
24. Paltauf-Dobruzynska J, Graier WF. Temperature dependence of agonist-stimulated Ca2+ signaling in cultured endothelial cells. Cell Calcium. 1997;21:4351.[Medline] [Order article via Infotrieve]
25. Morgan KG. Ca2+i versus [Ca2+]i. Biophys J. 1993;65:561562.[Medline] [Order article via Infotrieve]
26.
Graier WF, Paltauf-Doburzynska J, Hill B, Fleischhacker
E, Hoebel BG, Kostner GM, Sturek M. Submaximal stimulation of porcine
endothelial cells causes focal
Ca2+ elevation beneath the cell
membrane. J Physiol (Lond). 1998;506:109125.
27. Vieira L, Slotki I, Cabantchik ZI. Chloride conductive pathways which support electrogenic H+ pumping by leishmania major promastigotes. J Biochem Chem. 1995;270:52995304.
28.
Groschner K, Graier WF, Kukovetz WR. Histamine induces
K+, Ca2+, and
Cl- currents in human vascular
endothelial cells: role of ionic currents in
stimulation of nitric oxide biosynthase. Circ Res. 1994;75:304314.
29. Krasznai Z, Márián T, Balkay L, Emri M, Trón L. Flow cytometric determination of absolute membrane potential of cells. J Photochem Photobiol B. 1995;28:9399.[Medline] [Order article via Infotrieve]
30. Shinitzky M, Barenholz Y. Fluidity parameters of lipid regions determined by fluorescence polarization. Biochim Biophys Acta. 1978;515:367394.[Medline] [Order article via Infotrieve]
31. Graier WF, Simecek S, Bowles DK, Sturek M. Heterogeneity of caffeine and bradykinin-sensitive stores in vascular endothelial cells. Biochem J. 1994;300:637641.
32. Schilling WP, Elliott SJ. Ca2+ signaling mechanisms of vascular endothelial cells and their role in oxidant-induced endothelial dysfunction. Am J Physiol. 1992;262(Heart Circ Physiol 31):H1617H1630.
33. Doan TN, Gentry DL, Taylor AA, Elliott SJ. Hydrogen peroxide activates agonist-sensitive Ca2+-flux pathways in canine venous endothelial cells. Biochem J. 1994;297:209215.
34.
Tan CM, Xenoyannis S, Feldman RD. Oxidant stress
enhances adenylyl cyclase activation. Circ Res. 1995;77:710717.
35.
Vostal JG, Shafer BJ. Thapsigargin-induced calcium
influx in the absence of detectable tyrosine
phosphorylation in human platelets. J
Biol Chem. 1996;271:1952419529.
36.
Corson MA, James NL, Latta SE, Nerem RM, Berk BC,
Harrison DG. Phosphorylation of
endothelial nitric oxide synthase in response to fluid
shear stress. Circ Res. 1996;79:984991.
37. Wang JP, Tsao LT, Raung SL, Lin CN. Investigation of the inhibitory effect of broussochalcone A on respiratory burst in neutrophils. Eur J Pharmacol. 1997;320:201208.[Medline] [Order article via Infotrieve]
38. Hess DT, Lin LH, Freeman JA, Norden JJ. Modification of cysteine residues within G(o) and other neuronal proteins by exposure to nitric oxide. Neuropharmacology. 1994;33:12831292.[Medline] [Order article via Infotrieve]
39. Persad S, Takeda S, Panagia V, Dhalla NS. ß-Adrenoceptor-linked signal transduction in ischemic-reperfused heart and scavenging of oxyradicals. J Mol Cell Cardiol. 1997;29:545558.[Medline] [Order article via Infotrieve]
40. Adams DJ, Barakeh J, Van Breemen C. Ion channels and regulation of intracellular calcium in vascular endothelial cells. FASEB J. 1989;3:23892400.[Abstract]
41. Berridge MJ. Capacitative calcium entry. Biochem J. 1995;312:111.
42. Groschner K, Graier WF, Kukovetz WR. Activation of a small-conductance Ca2+-dependent K+ channel contributes to bradykinin-induced stimulation of nitric oxide synthesis in pig aortic endothelial cells. Biochim Biophys Acta. 1992;1137:162170.[Medline] [Order article via Infotrieve]
43. Busse R, Lückhoff A, Mülsch A. Cellular mechanisms controlling EDRF/NO formation in endothelial cells. Basic Res Cardiol. 1991;86(suppl 2):716.
44. Graier WF, Kukovetz WR, Groschner K. cAMP enhances agonist-induced Ca2+ entry into endothelial cells by activation of potassium channels and membrane hyperpolarization. Biochem J. 1993;291:263267.
45. Minor PLJ, Myers PR, Guerra R, Bates JN, Harrison DG. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest. 1990;86:21092116.
46.
Cherry PD, Omar HA, Farrell KA, Stuart JS, Wolin MS.
Superoxide anion inhibits cGMP-associated bovine pulmonary
arterial relaxation. Am J Physiol. 1990;259:H1056H1062.
47. Jain S, Thomas M, Kumar GP, Laloraya M. Programmed lipid peroxidation of biomembranes generating kinked phospholipids permitting local molecular mobility: a peroxidative theory of fluidity management. Biochem Biophys Res Commun. 1993;195:574580.[Medline] [Order article via Infotrieve]
48. Deliconstantinos G, Villiotou V, Stavrides JC. Modulation of particulate nitric oxide synthase activity and peroxynitrite synthesis in cholesterol enriched endothelial cell membranes. Biochem Pharmacol. 1995;49:15891600.[Medline] [Order article via Infotrieve]
49. Natsuki R, Yamaguchi T. Effects of ethanol on phospholipases in the mouse brain, heart and liver. Biol Pharm Bull. 1996;19:525529.[Medline] [Order article via Infotrieve]
50. de Jonge HW, Dekkers DH, Bastiaanse EM, Bezstarosti K, van der Laarse A, Lamers JM. Eicosapentaenoic acid incorporation in membrane phospholipids modulates receptor-mediated phospholipase C and membrane fluidity in rat ventricular myocytes in culture. J Mol Cell Cardiol. 1996;28:10971108.[Medline] [Order article via Infotrieve]
51. Koshlukova SE, Markovska TT, Pankov RG, Momchilova AB, Koumanov KS. Alteration in microsomal and plasma membranes during liver regeneration. Biochimie. 1992;74:981987.[Medline] [Order article via Infotrieve]
52. Eckert A, Forstl H, Zerfass R, Hartmann H, Muller WE. Lymphocytes and neutrophils as peripheral models to study the effect of ß-amyloid on cellular calcium signaling in Alzheimer's disease. Life Sci. 1996;59:499510.[Medline] [Order article via Infotrieve]
53. Peoples RW, Li C, Weight FF. Lipids vs protein theories of alcohol action in the nervous system. Annu Rev Pharmacol Toxicol. 1996;36:185201.[Medline] [Order article via Infotrieve]
54. Graier WF, Posch K, Wascher TC, Kukovetz WR, Kostner GM. Role of superoxide anions in changes of endothelial vasoactive response during acute hyperglycemia. Horm Metab Res. 1997;29:622629.[Medline] [Order article via Infotrieve]
55.
Fleming I, Fisslthaler B, Busse R. Interdependence of
calcium signaling and protein tyrosine phosphorylation
in human endothelial cells. J Biol
Chem. 1996;271:1100911015.
56.
Vaca LA, Kunze DL. Depletion and refilling of
intracellular Ca2+ stores induce
oscillations of Ca2+ current.
Am J Physiol. 1993;264:H1319H1322.
This article has been cited by other articles:
![]() |
D. M. Brown, K. Donaldson, P. J. Borm, R. P. Schins, M. Dehnhardt, P. Gilmour, L. A. Jimenez, and V. Stone Calcium and ROS-mediated activation of transcription factors and TNF-{alpha} cytokine gene expression in macrophages exposed to ultrafine particles Am J Physiol Lung Cell Mol Physiol, February 1, 2004; 286(2): L344 - L353. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Thum and J. Borlak Mechanistic Role of Cytochrome P450 Monooxygenases in Oxidized Low-Density Lipoprotein-Induced Vascular Injury: Therapy Through LOX-1 Receptor Antagonism? Circ. Res., January 9, 2004; 94 (1): e1 - e13. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. V. Usatyuk, V. P. Fomin, S. Shi, J. G. N. Garcia, K. Schaphorst, and V. Natarajan Role of Ca2+ in diperoxovanadate-induced cytoskeletal remodeling and endothelial cell barrier function Am J Physiol Lung Cell Mol Physiol, November 1, 2003; 285(5): L1006 - L1017. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Ortiz and J. L. Garvin Superoxide stimulates NaCl absorption by the thick ascending limb Am J Physiol Renal Physiol, November 1, 2002; 283(5): F957 - F962. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Gunnett, D. D. Heistad, and F. M. Faraci Interleukin-10 Protects Nitric Oxide-Dependent Relaxation During Diabetes: Role of Superoxide Diabetes, June 1, 2002; 51(6): 1931 - 1937. [Abstract] [Full Text] [PDF] |
||||
![]() |
M H Sarker and P A Fraser The role of guanylyl cyclases in the permeability response to inflammatory mediators in pial venular capillaries in the rat J. Physiol., April 1, 2002; 540(1): 209 - 218. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M Leach, H. M Hill, V. A Snetkov, T. P Robertson, and J. P T Ward Divergent roles of glycolysis and the mitochondrial electron transport chain in hypoxic pulmonary vasoconstriction of the rat: identity of the hypoxic sensor J. Physiol., October 1, 2001; 536(1): 211 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Gunnett, D. D. Heistad, D. J. Berg, and F. M. Faraci IL-10 deficiency increases superoxide and endothelial dysfunction during inflammation Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1555 - H1562. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.H. Sarker and P. A. Fraser The role of guanylyl cyclases in the permeability response to inflammatory mediators in pial venular capillaries in the rat J. Physiol., February 15, 2002; (2002) 200101291. [Abstract] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |